EULAR® 2024 Insights
Crystal Arthropathies
EULAR® 2024 Insights
New Phase 3 Study: DISSOLVE 1- Potential Future Implications for the Treatment of Chronic Gout
FEATURING
Alan Kivitz
- 157 views
- August 21, 2024
EULAR® 2024 Insights
EULAR® 2024 Insights: Support Needs of Gout Patients and Suitability of eHealth to Address These Needs
FEATURING
Jeffrey Van Der Ven
- 499 views
- June 26, 2024
- 1
EULAR® 2024 Insights
Clinical Implications of DISSOLVE I Phase 3, Double-Blind, Placebo-Controlled Clinical Trial for Gout Patients
FEATURING
Alan Kivitz
- 145 views
- June 21, 2024
- 2